Results 141 to 150 of about 18,807 (182)

Helicobacter pylori Eradication According to Sequencing-Based 23S Ribosomal RNA Point Mutation Associated with Clarithromycin Resistance. [PDF]

J Clin Med, 2019
Seo SI, Do BJ, Kang JG, Kim HS, Jang MK, Kim HY, Shin WG.   +6 more
europepmc   +1 more source

Improved Performance Predicting Clarithromycin Resistance in <i>Mycobacterium abscessus</i> on an Independent Data Set. [PDF]

Antimicrob Agents Chemother, 2019
Lipworth S, Hough N, Buchanan R, Smith EG, Robinson E, Alexander E, Peto T, Crook D, Walker T.   +8 more
europepmc   +1 more source

Comparative effectiveness of genotype-guided and empirical bismuth-containing quadruple therapy for <i>Helicobacter pylori</i> eradication: a retrospective study. [PDF]

Front Pharmacol
Wang P, Yang M, Zhao X, Ding H, Cheng J.
europepmc   +1 more source

Reconsidering First-Line Therapy for Clarithromycin-Resistant <i>Helicobacter pylori</i> in Korea: The Role of Bismuth-Augmented Triple Therapy. [PDF]

Gut Liver
Park JK, Huh CW.
europepmc   +1 more source

Macrolide-resistant <i>Mycobacterium avium</i> complex pulmonary disease: A narrative review. [PDF]

J Clin Tuberc Other Mycobact Dis
Cumar Y, Forsman LD, Schön T, Wejse C, Dahl VN.   +4 more
europepmc   +1 more source

Fourteen-Day Amoxicillin- or Tetracycline-Containing Bismuth Quadruple Therapy versus 14-Day Metronidazole-Based Triple Therapy as the Treatment for Clarithromycin-Resistant <i>Helicobacter pylori</i> Infection: A Multicenter Randomized Controlled Trial. [PDF]

Gut Liver
Koh M, Choi CW, Ryu DG, Yu SJ, Kim SE, Jung K, Lee BE, Lee MW, Joo DC, Lee J, Cha RR, Jee SR.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Prevalence of Helicobacter pylori resistance to clarithromycin in Tunisia

Journal of Medical Microbiology, 2022
Background. Helicobacter pylori (H. pylori) resistance to clarithromycin is increasing worldwide. Data on the prevalence of H.
Manel Moalla, Hela Gdoura, Hend Smaoui   +2 more
exaly   +3 more sources

Clarithromycin resistance of Helicobacter pylori has a major impact on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy

Pathologie Et Biologie, 2001
Clarithromycin resistance of Helicobacter pylori is relatively frequent in France and is assumed to be the main cause of failure of the proton pump inhibitor-amoxicillin-clarithromycin (PPI-AC) therapy, which is the first-line regimen in our country. We determined the respective effects of clarithromycin primary and secondary resistances on efficacy of
C Lascols
exaly   +3 more sources

Lipopolysaccharide glycotyping of clarithromycin-resistant and clarithromycin-susceptible Canadian isolates ofHelicobacter pylori

Canadian Journal of Microbiology, 2014
Lipopolysaccharide (LPS) of Helicobacter pylori exhibits several unique structures, such as Lewis (Le) antigens, α-1,6-glucan, and dd-heptan. To investigate the relationship between LPS structure and resistance to clarithromycin, 41 Canadian isolates of H. pylori were characterized by whole-cell ELISA (enzyme-linked immunosorbent assay), sugar analysis,
Altman, E., Harrison, B.A., Chandan, V., Slinger, R.   +3 more
openaire   +2 more sources

Helicobacter pylori resistance to clarithromycin in Reunion Island

Médecine et Maladies Infectieuses, 2016
The increasing resistance of Helicobacter pylori to clarithromycin led to developing new eradication treatment regimens. The objective of our observational study was to determine the proportion of H. pylori strains resistant to clarithromycin in infected patients in Reunion Island and to suggest a first-line treatment in agreement with the local ...
Zemali, N., Guillemot, G., Jaubert, J., Picot, S., Thomas, E., Becquart, J.P., Camuset, G., Gérardin, Patrick, Michault, A., Kwiatek, S.   +9 more
openaire   +2 more sources